Observational study / 2010
Use of the weight-loss supplement Hydroxycut was linked to severe liver injury, acute liver failure, and death.
Researchers analyzed 8 patients from medical centers and 9 cases from the FDA MedWatch database who developed liver injury after taking Hydroxycut. All 8 center patients were hospitalized, with 3 requiring liver transplantation, and the FDA cases included 1 fatal case of acute liver failure. Causality adjudication using DILIN methodology classified 8 cases as definite, 5 as highly likely, 2 as probable, and 2 as possible. Most patients presented with a hepatocellular pattern of injury, typically experiencing jaundice, fatigue, nausea, vomiting, and abdominal pain.
Shows an association, not proof of cause and effect.
- Study type
- Case series
- Who was studied
- 17 patients (8 from medical centers, 9 from FDA MedWatch)
- What was measured
- Clinical presentation, severity, and causality of liver injury
THE PAPER
Hepatotoxicity due to hydroxycut: a case series.
Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ, Hayashi P, Lee WM, Seeff LB. Am J Gastroenterol, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.